184 related articles for article (PubMed ID: 26981554)
1. Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors.
Openshaw MR; Harvey RA; Sebire NJ; Kaur B; Sarwar N; Seckl MJ; Fisher RA
EBioMedicine; 2016 Feb; 4():146-52. PubMed ID: 26981554
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
3. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
4. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study.
Luo L; Lin L; Zhang X; Cai Q; Zhao H; Xu C; Cong Q
Biomed Res Int; 2020; 2020():1314967. PubMed ID: 31998776
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
7. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
8. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
9. Gestational Trophoblastic Disease: Clinical and Imaging Features.
Shaaban AM; Rezvani M; Haroun RR; Kennedy AM; Elsayes KM; Olpin JD; Salama ME; Foster BR; Menias CO
Radiographics; 2017; 37(2):681-700. PubMed ID: 28287945
[TBL] [Abstract][Full Text] [Related]
10. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
12. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
15. Association of ß-hCG Surveillance with Emotional, Reproductive, and Sexual Health in Women Treated for Gestational Trophoblastic Neoplasia.
Jewell EL; Aghajanian C; Montovano M; Lewin SN; Baser RE; Carter J
J Womens Health (Larchmt); 2018 Mar; 27(3):387-393. PubMed ID: 29267150
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
18. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
[TBL] [Abstract][Full Text] [Related]
19. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
Yanaranop M; Potikul C; Tuipae S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
Hromadnikova I; Kotlabova K; Krofta L; Hron F
Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
